Cognition Therapeutics Inc
NASDAQ:CGTX
Cash Flow Statement
Cash Flow Statement
Cognition Therapeutics Inc
| Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||||
| Net Income |
(5)
|
(7)
|
(6)
|
(12)
|
(16)
|
(20)
|
(24)
|
(21)
|
(24)
|
(23)
|
(23)
|
(26)
|
(29)
|
(31)
|
(34)
|
(34)
|
(33)
|
(33)
|
(28)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
|
| Stock-Based Compensation |
0
|
1
|
0
|
5
|
6
|
7
|
8
|
4
|
4
|
3
|
3
|
4
|
3
|
4
|
4
|
4
|
3
|
3
|
2
|
|
| Other Non-Cash Items |
0
|
0
|
0
|
5
|
7
|
8
|
8
|
4
|
4
|
4
|
5
|
5
|
5
|
5
|
5
|
4
|
3
|
3
|
3
|
|
| Change in Working Capital |
0
|
1
|
2
|
3
|
3
|
2
|
7
|
(1)
|
1
|
2
|
(3)
|
5
|
3
|
3
|
4
|
1
|
(1)
|
(1)
|
(4)
|
|
| Cash from Operating Activities |
(5)
N/A
|
(6)
-19%
|
(4)
+25%
|
(4)
+14%
|
(6)
-61%
|
(10)
-76%
|
(8)
+20%
|
(19)
-125%
|
(18)
+2%
|
(17)
+9%
|
(21)
-25%
|
(16)
+23%
|
(21)
-28%
|
(23)
-11%
|
(26)
-12%
|
(28)
-11%
|
(31)
-9%
|
(31)
+1%
|
(30)
+4%
|
|
| Investing Cash Flow | ||||||||||||||||||||
| Capital Expenditures |
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
|
| Cash from Investing Activities |
0
N/A
|
0
N/A
|
0
N/A
|
(0)
N/A
|
(0)
-433%
|
(0)
-6%
|
(0)
-12%
|
(0)
+11%
|
(0)
+53%
|
(0)
-13%
|
(0)
-44%
|
(0)
-13%
|
(0)
+27%
|
(0)
+16%
|
(0)
+67%
|
(0)
+87%
|
0
N/A
|
0
N/A
|
(0)
N/A
|
|
| Financing Cash Flow | ||||||||||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
0
|
45
|
45
|
45
|
46
|
7
|
7
|
9
|
8
|
5
|
17
|
15
|
15
|
24
|
14
|
14
|
48
|
|
| Net Issuance of Debt |
2
|
2
|
0
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
|
| Other |
9
|
8
|
7
|
9
|
0
|
1
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Cash from Financing Activities |
11
N/A
|
10
-11%
|
7
-26%
|
53
+630%
|
44
-17%
|
45
+2%
|
47
+4%
|
6
-88%
|
6
+1%
|
8
+44%
|
7
-11%
|
5
-37%
|
17
+265%
|
14
-14%
|
15
+2%
|
24
+61%
|
13
-45%
|
14
+7%
|
47
+244%
|
|
| Change in Cash | ||||||||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Change in Cash |
6
N/A
|
4
-33%
|
3
-26%
|
50
+1 513%
|
38
-23%
|
34
-10%
|
38
+11%
|
(13)
N/A
|
(13)
+3%
|
(9)
+33%
|
(14)
-59%
|
(12)
+15%
|
(4)
+65%
|
(9)
-110%
|
(11)
-26%
|
(5)
+55%
|
(18)
-271%
|
(17)
+7%
|
18
N/A
|
|
| Free Cash Flow | ||||||||||||||||||||
| Free Cash Flow |
(5)
N/A
|
(6)
-19%
|
(4)
+25%
|
(4)
+13%
|
(6)
-64%
|
(10)
-74%
|
(8)
+19%
|
(19)
-122%
|
(18)
+2%
|
(17)
+9%
|
(21)
-25%
|
(16)
+23%
|
(21)
-28%
|
(23)
-11%
|
(26)
-11%
|
(28)
-11%
|
(31)
-9%
|
(31)
+1%
|
(30)
+4%
|
|